Global Sleep Disorders Market Overview:
Sleep disorders are a bunch of conditions that have an effect on the ability to sleep well on a daily basis. Whether or not they are caused by a health problem or by an excessive amount of stress, sleep disorders are getting progressively common across the world. Most people sometimes experience sleeping problems because of stress, hectic schedules, and different outside influences. However, once these issues begin to occur on an everyday basis and interfere with daily life, they may indicate a sleeping disorder. Depending on the kind of disorder, people could have a difficult time falling asleep and may feel extremely tired throughout the day. The shortage of sleep can have a negative impact on energy, mood, concentration, and overall health. Some of the players profiled in the study are GlaxoSmithKline plc (United Kingdom), Becton Dickson and Company (United States), Natus Medical Incorporated (United States), Cardinal Health (United States), Koninklijke Philips N.V. (Netherlands), Teva Pharmaceutical Industries Ltd. (Israel), Takeda Pharmaceutical Company Limited (Japan), fizer Inc (United States), Sanofi (France) and Merck & Co Inc (United States).
On the basis of geography, the market of Sleep Disorders has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Category, the sub-segment i.e. Insomnia will boost the Sleep Disorders market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Treatment, the sub-segment i.e. Psychiatric treatment will boost the Sleep Disorders market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Medication, the sub-segment i.e. Prescription-based Drugs will boost the Sleep Disorders market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Growth Drivers
- Significant Rise in the Prevalence of Sleep Disorders
- The Increasing Usage of Social Media and Growing Addiction of Gadgets
- Ongoing Research on Ill-Effects of Sleep Deprivation
- The Growing Adoption of Sleep Clinics
- Increase in Patent Expirations
- Emergence of Generics
- Side-Effects Associated With Sleep Disorder Drugs
- The Rising Demand from Developed & Developing Countries
- Introduction of Home Sleep Test Kits
- Utilization of Wearable Monitors & Continuous Positive Airway Pressure (CPAP) Therapy
Key Market Developments:
On Feb. 27, 2018 The Center for Craniofacial & Dental Sleep Medicine (CFDSM), a Houston-based company specializing in dental sleep medicine and sleep apnea treatment, announced that it has received FDA clearance on its innovative new treatment for obstructive sleep apnea (OSA) and snoring, The Meridian PM oral appliance.
Sleeping Disorder treatment product manufacturers, Sleeping Disorder treatment dealers and suppliers, Sleeping Disorder associations, Academic institutions, Venture capitalists, Consulting firms and Government bodies
Major Objectives Focused through this Study
To define, describe, and forecast the Global Sleep Disorders market on the basis of product [Mattresses and Pillows, Sleep Laboratories, Medications and Sleep Disorder Devices] , application , key regions and end user
To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
To provide market size for various segments of the Sleep Disorders market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
To strategically profile the key players and analyzing their market shares and core competencies in the Sleep Disorders industry
To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market
Available Customization: Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are GlaxoSmithKline plc (United Kingdom) and Natus Medical Incorporated (United States).
** Confirmation on availability of data would be informed prior purchase
While framing the research framework, major and emerging players operating in the Sleep Disorders market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.